Device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation: pro.

27 August 2022 (08:30 - 08:45)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Professor Giuseppe Boriani

Modena Polyclinic Modena University Hospital, Modena (Italy)

5 More presentations in this session

Presentation thumbnail

Device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation: con.

Professor I. Van Gelder (Groningen, NL)

Presentation thumbnail

Device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation – the final word.

Presentation thumbnail

All patients with heart failure and atrial fibrillation should undergo atrial fibrillation ablation: pro.

Professor L. Di Biase (The Bronx, US)

Presentation thumbnail

All patients with heart failure and atrial fibrillation should undergo atrial fibrillation ablation: con.

Doctor A. Verma (Montreal, CA)

Presentation thumbnail

All patients with heart failure and atrial fibrillation should undergo atrial fibrillation ablation – the final word.

Access the full session

Session thumbnail

Great Debate: device-detected subclinical AF should be treated like clinical AF. All patients with HF and AF should undergo AF ablation

The Event

Event poster

ESC Congress 2022

27 August 2022 08:30 CET

You may be interested in

Congress Presentation

Device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation: con.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources